Eikon
Eikon Therapeutics is a biopharmaceutical company that integrates Nobel Prize-winning super-resolution single-molecule tracking (SMT) microscopy, advanced engineering, automation, and high-performance computing to visualize and measure the real-time movement of individual proteins in living cells. This proprietary live-cell imaging platform screens protein-ligand interactions across millions of cells per day, generating large, high-dimensional datasets that power the discovery and development of novel small-molecule medicines. Eikon advances a clinical- and preclinical-stage oncology and immunology pipeline, including EIK1001 (a TLR7/8 agonist) and IMP1734 (a selective PARP1 inhibitor). Backed by General Catalyst, the company is headquartered in Millbrae, California with offices in New York and Jersey City.
Eikon is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Drug Discovery.
Eikon’s developer surface includes product news, engineering blog, support, and 10 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 2
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.